BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: James JP, Riis LB, Malham M, Høgdall E, Langholz E, Nielsen BS. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. Int J Mol Sci 2020;21:E7893. [PMID: 33114313 DOI: 10.3390/ijms21217893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Kitae H, Takagi T, Naito Y, Inoue R, Azuma Y, Torii T, Mizushima K, Doi T, Inoue K, Dohi O, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Konishi H, Itoh Y. Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis. Microorganisms 2022;10:1044. [DOI: 10.3390/microorganisms10051044] [Reference Citation Analysis]
2 Grillo TG, Quaglio AEV, Beraldo RF, Lima TB, Baima JP, Di Stasi LC, Sassaki LY. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World J Gastrointest Oncol 2021; 13(9): 995-1016 [PMID: 34616508 DOI: 10.4251/wjgo.v13.i9.995] [Reference Citation Analysis]
3 Herrnreiter CJ, Li X, Luck ME, Zilliox MJ, Choudhry MA. Integrated analysis of dysregulated microRNA and mRNA expression in intestinal epithelial cells following ethanol intoxication and burn injury. Sci Rep 2021;11:20213. [PMID: 34642361 DOI: 10.1038/s41598-021-99281-1] [Reference Citation Analysis]
4 Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2020;22:E362. [PMID: 33396382 DOI: 10.3390/ijms22010362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
5 Amerikanou C, Papada E, Gioxari A, Smyrnioudis I, Kleftaki SA, Valsamidou E, Bruns V, Banerjee R, Trivella MG, Milic N, Medić-Stojanoska M, Gastaldelli A, Kannt A, Dedoussis GV, Kaliora AC; MAST4HEALTH. Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. Pharmacol Res 2021;171:105753. [PMID: 34224858 DOI: 10.1016/j.phrs.2021.105753] [Reference Citation Analysis]
6 Zhang LZ, Xue H, Qiao CX, You WL, Di AT, Zhao G. MiR-223 promotes pyroptosis of enteritis cells through activating NF-κB signalling pathway by targeting SNIP1 in inflammatory bowel disease. Autoimmunity 2021;54:362-72. [PMID: 34151668 DOI: 10.1080/08916934.2021.1940973] [Reference Citation Analysis]
7 Almeida-Lousada H, Mestre A, Ramalhete S, Price AJ, de Mello RA, Marreiros AD, Neves RPD, Castelo-Branco P. Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers? Curr Oncol 2021;28:4874-93. [PMID: 34898591 DOI: 10.3390/curroncol28060411] [Reference Citation Analysis]
8 Gong QQ, Dou ZL, Wang X, Zhang KY, Chen H, Gao JG, Sun XY. Epididymal initial segment-specific Cre recombinase activity in Lcn8-Cre knock-in mice. Mol Biol Rep 2021. [PMID: 34328598 DOI: 10.1007/s11033-021-06604-6] [Reference Citation Analysis]
9 Allenspach K, Mochel JP. Current diagnostics for chronic enteropathies in dogs. Vet Clin Pathol 2021. [PMID: 34699081 DOI: 10.1111/vcp.13068] [Reference Citation Analysis]
10 Jiang F, Fu X, Kuang K, Fan D, Koundal D. Artificial Intelligence Algorithm-Based Differential Diagnosis of Crohn’s Disease and Ulcerative Colitis by CT Image. Computational and Mathematical Methods in Medicine 2022;2022:1-12. [DOI: 10.1155/2022/3871994] [Reference Citation Analysis]
11 Yan Y, Xing C, Xiao Y, Shen X, Zhang Z, He C, Shi JB, Liu M, Liu X. Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease In Vivo. J Med Chem 2022. [PMID: 35536548 DOI: 10.1021/acs.jmedchem.2c00356] [Reference Citation Analysis]
12 Xu J, Xu H, Yang M, Liang Y, Peng Q, Zhang Y, Tian C, Wang L, Yao J, Nie Y, Li D. New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease. Front Pharmacol 2022;13:813659. [DOI: 10.3389/fphar.2022.813659] [Reference Citation Analysis]
13 Stiegeler S, Mercurio K, Iancu MA, Corr SC. The Impact of MicroRNAs during Inflammatory Bowel Disease: Effects on the Mucus Layer and Intercellular Junctions for Gut Permeability. Cells 2021;10:3358. [PMID: 34943865 DOI: 10.3390/cells10123358] [Reference Citation Analysis]
14 Liu X, Zheng X, Wang Y, Liu J. Dysregulation Serum miR-19a-3p is a Diagnostic Biomarker for Asymptomatic Carotid Artery Stenosis and a Promising Predictor of Cerebral Ischemia Events. Clin Appl Thromb Hemost 2021;27:10760296211039287. [PMID: 34558328 DOI: 10.1177/10760296211039287] [Reference Citation Analysis]
15 Malham M, James JP, Jakobsen C, Hoegdall E, Holmstroem K, Wewer V, Nielsen BS, Riis LB. Mucosal microRNAs relate to age and severity of disease in ulcerative colitis. Aging (Albany NY) 2021;13:6359-74. [PMID: 33647883 DOI: 10.18632/aging.202715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tsuji K, Kitamura S, Wada J. MicroRNAs as Biomarkers for Nephrotic Syndrome. Int J Mol Sci 2020;22:E88. [PMID: 33374848 DOI: 10.3390/ijms22010088] [Reference Citation Analysis]
17 Liu D, Saikam V, Skrada KA, Merlin D, Iyer SS. Inflammatory bowel disease biomarkers. Medicinal Research Reviews. [DOI: 10.1002/med.21893] [Reference Citation Analysis]